At least six confirmed COVID-19 patients have been enrolled in a clinical trial testing the arthritis drug Actemra.
According to Business Insider, researchers are studying the drug as a potential COVID-19 treatment.
The study enrolled the first patients last Friday in the US and Spain.
The study is investigating if the medication can help severe COVID-19 patients suffering from pneumonia recover.